New research from LUMC shows that a specialized clinical pathway for SCAD is a safe and effective approach for this rare heart disease. Patients treated within this pathway underwent fewer invasive procedures and received less unnecessary medication, without increased risk. Aftercare is a key part of the clinical pathway and supports patients in returning to daily life after a heart attack and rebuilding confidence in their bodies.
Read more&width=710&height=710)
A driving force
LUMC strongly underpins the idea that ‘Science is the driving force behind innovative healthcare’. Outcomes of top level fundamental, translational and clinical research by LUMC researchers form a strong basis for innovative and qualitative healthcare on a national, European and international level.
A real game changer was the development of the Dutch national research agenda (NWA) in 2015. The agenda reveals the complexity of the issues challenging Dutch society today. These issues are clustered in so called routes. LUMC is involved in many of these routes and contributes this way to solving important societal challenges.